NCT02720640View on ClinicalTrials.gov

Safety and Efficacy of the Alpha AMS Subretinal Implant

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Retinitis Pigmentosa
Interventions
DEVICE

Implant 'on' vs implant 'off'

Single group assignment

Trial Locations (1)

OX3 9DU

Oxford University Hospitals NHS Foundation Trust, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT02720640 - Safety and Efficacy of the Alpha AMS Subretinal Implant | Biotech Hunter | Biotech Hunter